Polysaccharides, Bacterial
"Polysaccharides, Bacterial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Polysaccharides found in bacteria and in capsules thereof.
| Descriptor ID |
D011135
|
| MeSH Number(s) |
D09.698.718 D23.050.161.616
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Polysaccharides, Bacterial".
Below are MeSH descriptors whose meaning is more specific than "Polysaccharides, Bacterial".
This graph shows the total number of publications written about "Polysaccharides, Bacterial" by people in this website by year, and whether "Polysaccharides, Bacterial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polysaccharides, Bacterial" by people in Profiles.
-
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine. 2013 Aug 02; 31(35):3585-93.
-
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. Vaccine. 2013 Aug 02; 31(35):3577-84.
-
Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Vaccine. 2013 Aug 02; 31(35):3594-602.
-
Knowledge of interim recommendations and use of Hib vaccine during vaccine shortages. Pediatrics. 2010 May; 125(5):914-20.
-
Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use. J Infect Dis. 1992 Jun; 165 Suppl 1:S139-43.
-
Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J. 1991 Feb; 10(2):92-6.
-
Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccine. Pediatr Infect Dis J. 1988 Mar; 7(3):149-56.